About: Treatment of SARS with human interferons

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Treatment of SARS with human interferons Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 July 2003

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в липні 2003 (uk) article scientifique publié en 2003 (fr) im Juli 2003 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu en xunetu de 2003 (ast) գիտական հոդված հրատարակված 2003 թվականի հուլիսի 1-ին (hy) scientific article published on 01 July 2003 (en)
publication date	wds:Q73738906-BAB07F9F-BA5E-4F42-BD40-3507AA5E1A92
publication date	2003-07-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q73738906-B09AA2C7-0A46-4916-B34F-17D65BE6640B
language of work or name	English
cites work	wds:Q73738906-2C2E417C-50DC-44B4-ACDC-8B33E2C8333A wds:Q73738906-43E2146B-9941-429B-AC4C-FF80210EF77F wds:Q73738906-57F4FC7C-4779-480F-90BF-CCE82FA8E590 wds:Q73738906-7D1A06C4-49C2-4016-A2EC-67213C6FD4CB wds:Q73738906-E9AE7A6C-811C-4F03-9DF8-94E3A8AF0D63
cites work	Identification of genes differentially regulated by interferon alpha, beta, or gamma using oligonucleotide arrays Glycyrrhizin, an active component of liquorice roots, and replication of SARS-associated coronavirus Identification of a novel coronavirus in patients with severe acute respiratory syndrome Quantitative real-time PCR detection of Rift Valley fever virus and its application to evaluation of antiviral compounds Lowered yields of virus-induced interferon production in leukocyte cultures and risk of recurrent respiratory infections in children
author name string	wds:Q73738906-502CDEEE-9C23-415F-AED4-49A7E4F98F2C wds:Q73738906-5C332E41-CA0E-4000-8E78-91FCBB813685 wds:Q73738906-606BD139-8714-498E-864A-908787C3D1FE wds:Q73738906-B3A63BE0-3C70-464D-9082-7FBFAC90AA7E wds:Q73738906-C47D4E66-58EF-48F1-9239-FFCC4DC6F0F8 wds:Q73738906-D0F5D387-AA71-4762-9D4B-ABC059800289
author name string	G Bauer P Chandra H W Doerr J Cinatl H Rabenau B Morgenstern
rdfs:label	Treatment of SARS with human interferons (en) Treatment of SARS with human interferons (nl)
skos:prefLabel	Treatment of SARS with human interferons (en) Treatment of SARS with human interferons (nl)
name	Treatment of SARS with human interferons (en) Treatment of SARS with human interferons (nl)
title	wds:Q73738906-2D8376DC-6F16-44FC-B43C-A5BC2A73CBDC
title	Treatment of SARS with human interferons (en)
page(s)	wds:Q73738906-A3084861-7902-462A-B2A6-66AFB7A312C7
page(s)	293-294
instance of	wds:Q73738906-DB8E25D9-3E42-47DF-B7E7-2F1AC18C8345
instance of	scholarly article
PubMed ID	wds:Q73738906-97B33646-843C-4CDA-A08B-F4CC9FAA8208
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/12892961
PubMed ID	12892961
published in	wds:Q73738906-173A01D9-8E29-4CDC-8BBC-E5E56EAB18C3
published in	The Lancet
issue	wds:Q73738906-F3AA6F0D-2861-48BA-ADCC-3EDD0787495F
volume	wds:Q73738906-49513B4D-99E1-4682-957F-9F40D9A4BEF3
issue	9380
volume	362
DOI	wds:Q73738906-61D3CFC2-8F36-4642-BED7-7BDC4D5EAAD2
DOI	http://dx.doi.org/10.1016/S0140-6736(03)13973-6
DOI	10.1016/S0140-6736(03)13973-6
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q73738906
is cites work of	Interference of ribosomal frameshifting by antisense peptide nucleic acids suppresses SARS coronavirus replication Recent developments in anti-severe acute respiratory syndrome coronavirus chemotherapy Stability and inactivation of SARS coronavirus ARDS in SARS: cytokine mediators and treatment implications. Growth kinetics of SARS-coronavirus in Vero E6 cells. Severe acute respiratory syndrome coronavirus as an agent of emerging and reemerging infection Molecular biology of severe acute respiratory syndrome coronavirus Molecular pathology of emerging coronavirus infections A new mouse-adapted strain of SARS-CoV as a lethal model for evaluating antiviral agents in vitro and in vivo Coronavirus pathogenesis and the emerging pathogen severe acute respiratory syndrome coronavirus Small molecules targeting severe acute respiratory syndrome human coronavirus Murine hepatitis virus strain 1 produces a clinically relevant model of severe acute respiratory syndrome in A/J mice. Coronaviruses - drug discovery and therapeutic options. Role of interferons in the treatment of severe acute respiratory syndrome Using siRNA in prophylactic and therapeutic regimens against SARS coronavirus in Rhesus macaque Ribavirin and interferon-beta synergistically inhibit SARS-associated coronavirus replication in animal and human cell lines. In vitro susceptibility of 10 clinical isolates of SARS coronavirus to selected antiviral compounds. Interferon-beta and interferon-gamma synergistically inhibit the replication of severe acute respiratory syndrome-associated coronavirus (SARS-CoV). HIV protease inhibitor nelfinavir inhibits replication of SARS-associated coronavirus The antiviral effect of interferon-beta against SARS-coronavirus is not mediated by MxA protein. Pegylated interferon-alpha protects type 1 pneumocytes against SARS coronavirus infection in macaques. PLP2, a potent deubiquitinase from murine hepatitis virus, strongly inhibits cellular type I interferon production Efficacy of various disinfectants against SARS coronavirus A severe acute respiratory syndrome-associated coronavirus-specific protein enhances virulence of an attenuated murine coronavirus Accessory protein 5a is a major antagonist of the antiviral action of interferon against murine coronavirus Severe acute respiratory syndrome coronavirus nsp1 protein suppresses host gene expression by promoting host mRNA degradation Severe acute respiratory syndrome coronavirus evades antiviral signaling: role of nsp1 and rational design of an attenuated strain The severe acute respiratory syndrome (SARS). SARS: pharmacotherapy SARS--beginning to understand a new virus Emerging viral infections in a rapidly changing world Severe acute respiratory syndrome (SARS)--paradigm of an emerging viral infection. Coronaviruses and their therapy Medical treatment of viral pneumonia including SARS in immunocompetent adult Antisense morpholino-oligomers directed against the 5' end of the genome inhibit coronavirus proliferation and growth Exogenous ACE2 expression allows refractory cell lines to support severe acute respiratory syndrome coronavirus replication Inhibition of novel β coronavirus replication by a combination of interferon-α2b and ribavirin The papain-like protease from the severe acute respiratory syndrome coronavirus is a deubiquitinating enzyme The impact of the SARS epidemic on the utilization of medical services: SARS and the fear of SARS Severe acute respiratory syndrome (SARS): lessons learnt in Hong Kong From SARS to MERS: 10 years of research on highly pathogenic human coronaviruses

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 190 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software